Clinical trials recruiting for Chronic Hepatitis B Virus (HBV) Infection
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| BRII-179 | 1 |
| BRII-835 (VIR-2218) | 1 |
| Collection of blood samples for the study of HBV biomarkers | 1 |
| Nucleos(t)ide Analogs (NA) | 1 |
| Peg-IFNα | 1 |
Self-screener
Recruiting trials
- A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
- New HBV Infection Biomarkers: Clinical Characterization and Impact on Management
- Non-Invasive Model for Fibrosis Regression in HBV Patients
Related conditions
Trials recruiting for Chronic Hepatitis B Virus (HBV) Infection often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Chronic Hepatitis B Virus (HBV) Infection trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.